Table 1.
Demographic data and mean (SD) values obtained at screening for the ASI for the mirtazapine and placebo treatment groups.
| Treatment | Mirtazapine | Placebo |
|---|---|---|
| N | 11 | 13 |
| Age | 43.8 years (5.6) | 47.2 years (6.7) |
| Female | 3 | 4 |
| Black | 9 | 10 |
| White | 2 | 0 |
| Other | 0 | 3 |
| ASI-ALC | .22 (.17) | .34 (.28) |
| ASI-DRUG | .21 (.07) | .23 (.10) |
| ASI-PSYCH | .39 (.30) | .34 (.15) |
| ASI-MED* | .16 (.26) | .52 (.41) |
| ASI-EMPL | .86 (.19) | .80 (.20) |
| ASI-LEG | .21 (.28) | .12 (.22) |
Notes: ASI, Addiction Severity Index; ASI Domains: ALC, Alcohol; PSYCH, Psychiatric; MED, Medical; EMPL, Employment; LEG; Legal.
*
p < .05 for between comparison.